 |
|
|
| |
REAL-WORLD PERSISTENCY OF PATIENTS RECEIVING TENOFOVIR-BASED PRE-EXPOSURE PROPHYLAXIS FOR THE PREVENTION OF HIV INFECTION IN THE US
|
| |
| |
Alan Oglesby,1 Guillaume Germain,2 François Laliberté,2 Staci Bush,1 Heidi Swygard,1 Sean MacKnight,2 Annalise Hilts,2 Mei S. Duh3
1ViiV Healthcare, Research Triangle Park, NC, USA; 2Groupe d'analyse, Ltée, Montréal, Québec, Canada; 3Analysis Group, Inc, Boston, MA
|
| |
|
|
|
|
|
